Position in BCRX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,429,860
+$521,015 QoQ
Shares Held
142,986
+49.8% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#104
of 316 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 19%
Shared 7%
None 75%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $96,211,937 across 30 Drug Manufacturers - Specialty & Generic names. BCRX ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
503,917 | $36,211,475 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
348,043 | $8,565,338 | |
| 3 | VTRS |
Viatris Inc
|
532,076 | $8,449,366 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,582 | $8,442,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
46,762 | $7,881,267 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
211,326 | $3,062,113 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
71,898 | $2,602,707 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
147,185 | $2,547,772 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,429,860 | 142,986 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $908,845 | 95,467 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $548,948 | 70,378 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $537,182 | 70,775 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||